News Image

Uncovering Noteworthy Technical Analysis Findings for REVOLUTION MEDICINES INC (NASDAQ:RVMD).

By Mill Chart

Last update: Feb 1, 2024

Our stock screener has identified REVOLUTION MEDICINES INC (NASDAQ:RVMD) as a potential breakout candidate. This technical breakout setup pattern occurs when the stock consolidates after a strong uptrend. While the actual breakout is uncertain, it may be worth keeping an eye on NASDAQ:RVMD.

RVMD Daily chart on 2024-02-01

What is the technical picture of NASDAQ:RVMD telling us.

ChartMill utilizes a proprietary algorithm to assign a Technical Rating to every stock. This rating, ranging from 0 to 10, is computed daily by analyzing a variety of technical indicators and properties.

Taking everything into account, RVMD scores 7 out of 10 in our technical rating. RVMD has been one of the better performers in the overall market. Some doubts were observed in the medium time frame, but recent action was again very positive.

  • The long and short term trends are both positive. This is looking good!
  • In the last month RVMD has a been trading in the 25.93 - 29.61 range, which is quite wide. It is currently trading in the middle of this range where prices have been consolidating recently, this may present a good entry opportunity, but some resistance may be present above.
  • Looking at the yearly performance, RVMD did better than 83% of all other stocks. However, this relatively good performance is mostly due to a recent big move.
  • RVMD is part of the Biotechnology industry. There are 601 other stocks in this industry, RVMD did better than 69% of them.
  • RVMD is currently trading in the middle of its 52 week range. The S&P500 Index however is currently trading near new highs, so RVMD is lagging the market.

Check the latest full technical report of RVMD for a complete technical analysis.

Looking at the Setup

In addition to the Technical Rating, ChartMill provides a Setup Rating for each stock. This rating, ranging from 0 to 10, assesses the level of consolidation in the stock based on multiple short-term technical indicators. Currently, NASDAQ:RVMD has a 9 as its setup rating, indicating its current consolidation status.

Besides having an excellent technical rating, RVMD also presents a decent setup pattern. Prices have been consolidating lately and the volatility has been reduced. There is a resistance zone just above the current price starting at 27.93. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 26.93, a Stop Loss order could be placed below this zone. Very recently a Pocket Pivot signal was observed. This is another positive sign.

How can NASDAQ:RVMD be traded?

To potentially initiate a trade, it is common practice to wait for the stock to break out of the consolidation zone. This breakout signifies a potential upward movement, and traders may enter the stock at that point. Conversely, if the stock falls back below the consolidation zone, it may be sold at a loss.

Disclaimer: This article is not intended to provide trading advice. It is crucial to conduct your own analysis and consider your own observations and trading style when making investment decisions. The article solely presents technical observations and should not be relied upon as a sole basis for trading.

Every day, new breakout setups can be found on ChartMill in our Breakout screener.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

REVOLUTION MEDICINES INC

NASDAQ:RVMD (4/19/2024, 7:14:32 PM)

After market: 34.92 0 (0%)

34.92

-0.91 (-2.54%)

RVMD News

News Image11 days ago - ChartmillTop movers in Tuesday's after hours session

Get insights into the top gainers and losers of Tuesday's after-hours session.

News Image11 days ago - Revolution Medicines, Inc.Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins

Simultaneous publication and presentation of RMC-6236 chemical structure, preclinical data and case studies during the “KRAS: Broadening the Attack Beyond...

News Image12 days ago - Revolution Medicines, Inc.Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins

Two original papers in Nature highlight the discovery and translational implications of RMC-7977, a RAS(ON) multi-selective tri-complex inhibitor that...

News Image16 days ago - Revolution Medicines, Inc.Revolution Medicines to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...

News Image23 days ago - Revolution Medicines, Inc.Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024

REDWOOD CITY, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...

News Image2 months ago - Revolution Medicines, Inc.Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress

Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time...

News Image2 months ago - Market News VideoFirst Week of September 20th Options Trading For Revolution Medicines (RVMD)
News Image2 months ago - Revolution Medicines, Inc.Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024

REDWOOD CITY, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel...

News Image2 months ago - Market News VideoCommit To Buy Revolution Medicines At $24, Earn 14.1% Annualized Using Options
News Image3 months ago - Revolution Medicines, Inc.Revolution Medicines to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...

News Image4 months ago - Revolution Medicines, Inc.Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference

REDWOOD CITY, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...

News Image4 months ago - InvestorPlacePharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development

These pharma stock leaders offer revolutionary treatments that could change the world of medicine (and investor's portfolios) for the better.

RVMD Links
Follow us for more